Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells

Stem Cells and Development

Volumn 23, Issue 4, 2014, Pages 333-351

  Bekhite, Mohamed M ^a,b   Finkensieper, Andreas ^a   Rebhan, Jennifer ^a   Huse, Stephanie ^a   Schultze Mosgau, Stefan ^a   Figulla, Hans Reiner ^a   Sauer, Heinrich ^c   Wartenberg, Maria ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Tanta University   (Egypt)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 3 [(3,5 DIMETHYL 2 PYRROLYL)METHYLENE] 2 INDOLINONE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANGIOPOIETIN RECEPTOR; BETA1 INTEGRIN; CASPASE 3; CD70 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; LEPTIN; LEPTIN RECEPTOR; MATRIGEL; NITRIC OXIDE SYNTHASE; OCTAMER TRANSCRIPTION FACTOR 4; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ANGIOGENESIS ASSAY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; HYPOXIC CELL; OXYGEN CONCENTRATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ABDOMINAL FAT; ADULT STEM CELLS; AGED; APOPTOSIS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; LEPTIN; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893707651     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0268     Document Type: Article

References (119)

1. Martinez-Estrada OM, Y Munoz-Santos, J Julve, M Reina and S Vilaro. (2005). Human adipose tissue as a source of Flk-1 + cells: new method of differentiation and expansion. Cardiovasc Res 65:328-333.
2. Taylor CJ, EM Bolton and JA Bradley. (2011). Immunological considerations for embryonic and induced pluripotent stem cell banking. Philos Trans R Soc Lond B Biol Sci 366:2312-2322.
3. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
4. Takahashi T, C Kalka, H Masuda, D Chen, M Silver, M Kearney, M Magner, JM Isner and T Asahara. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
5. Jackson KA, SM Majka, H Wang, J Pocius, CJ Hartley, MW Majesky, ML Entman, LH Michael, KK Hirschi and MA Goodell. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107:1395-1402.
6. Smits AM, P van Vliet, CH Metz, T Korfage, JP Sluijter, PA Doevendans and MJ Goumans. (2009). Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4: 232-243.
7. Dellavalle A, M Sampaolesi, R Tonlorenzi, E Tagliafico, B Sacchetti, L Perani, A Innocenzi, BG Galvez, G Messina and R Morosetti. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255-267.
8. Hung SC, NJ Chen, SL Hsieh, H Li, HL Ma and WH Lo. (2002). Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 20:249-258.
9. Bai X, K Pinkernell, YH Song, C Nabzdyk, J Reiser and E Alt. (2007). Genetically selected stem cells from human adipose tissue express cardiac markers. Biochem Biophys Res Commun 353:665-671.
10. Peran M, JA Marchal, E Lopez, M Jimenez-Navarro, H Boulaiz, F Rodriguez-Serrano, E Carrillo, G Sanchez- Espin, E de Teresa, D Tosh and A Aranega. (2010). Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy 12: 332-337.
11. Planat-Benard V, C Menard, M Andre, M Puceat, A Perez, JM Garcia-Verdugo, L Penicaud and L Casteilla. (2004). Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94:223-229.
12. Song YH, S Gehmert, S Sadat, K Pinkernell, X Bai, N Matthias and E Alt. (2007). VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochem Biophys Res Commun 354:999-1003.
13. Sanz-Ruiz R, ME Santos, MD Munoa, IL Martin, R Parma, PL Fernandez and F Fernandez-Aviles. (2008). Adipose tissue-derived stem cells: the friendly side of a classic cardiovascular foe. J Cardiovasc Transl Res 1:55-63.
14. Fraser JK, I Wulur, Z Alfonso and MH Hedrick. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 24:150-154.
15. Fantuzzi G. (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919.
16. Phillips LK and JB Prins. (2008). The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 10:156-164.
17. Madonna R and R De Caterina. (2010). Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown) 11:71-80.
18. Ogawa R, H Mizuno, A Watanabe, M Migita, T Shimada and H Hyakusoku. (2004). Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. Biochem Biophys Res Commun 313:871-877.
19. di Summa PG, PJ Kingham, W Raffoul, M Wiberg, G Terenghi and DF Kalbermatten. (2009). Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg 63:1544-1552.
20. Ryu HH, JH Lim, YE Byeon, JR Park, MS Seo, YW Lee, WH Kim, KS Kang and OK Kweon. (2009). Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. J Vet Sci 10:273-284.
21. Liang L, T Ma, W Chen, J Hu, X Bai, J Li and T Liang. (2009). Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res 39:822-832.
22. Kajiyama H, TS Hamazaki, M Tokuhara, S Masui, K Okabayashi, K Ohnuma, S Yabe, K Yasuda, S Ishiura, H Okochi and M Asashima. (2010). Pdx1-transfected adipose tissuederived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice. Int J Dev Biol 54:699-705.
23. Lu F, H Mizuno, CA Uysal, X Cai, R Ogawa and H Hyakusoku. (2008). Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 121:50-58.
24. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrowderived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549.
25. Rehman J, D Traktuev, J Li, S Merfeld-Clauss, CJ Temm- Grove, JE Bovenkerk, CL Pell, BH Johnstone, RV Considine and KL March. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298.
26. Lee JH and DM Kemp. (2006). Human adipose-derived stem cells display myogenic potential and perturbed function in hypoxic conditions. Biochem Biophys Res Commun 341:882-888.
27. Ferrara N and Davis-Smyth T. (1997). The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
28. Lee EY, Y Xia, WS Kim, MH Kim, TH Kim, KJ Kim, BS Park and JH Sung. (2009). Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17:540-547.
29. Kilroy GE, SJ Foster, X Wu, J Ruiz, S Sherwood, A Heifetz, JW Ludlow, DM Stricker, S Potiny and P Green. (2007). Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212:702-709.
30. Friedman JM and JL Halaas. (1998). Leptin and the regulation of body weight in mammals. Nature 395:763-770.
31. Zhang F, Y Chen, M Heiman and R Dimarchi. (2005). Leptin: structure, function and biology. Vitam Horm 71:345-372.
32. Schroeter MR, S Stein, NM Heida, M Leifheit-Nestler, IF Cheng, R Gogiraju, H Christiansen, LS Maier, AM Shah and G Hasenfuss. (2012). Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9. Cardiovasc Res 93: 170-180.
33. Sierra-Honigmann MR, AK Nath, C Murakami, G Garcia- Cardena, A Papapetropoulos, WC Sessa, LA Madge, JS Schechner, MB Schwabb, PJ Polverini and JR Flores- Riveros. (1998). Biological action of leptin as an angiogenic factor. Science 281:1683-1686.
34. Wolk R, A Deb, NM Caplice and VK Somers. (2005). Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 183:131-139.
35. Henson MC and VD Castracane. (2000). Leptin in pregnancy. Biol Reprod 63:1219-1228.
36. Matsui H, M Motooka, H Koike, M Inoue, T Iwasaki, T Suzuki, M Kurabayashi and T Yokoyama. (2007). Ischemia/ reperfusion in rat heart induces leptin and leptin receptor gene expression. Life Sci 80:672-680.
37. Ishikawa M, J Kitayama and H Nagawa. (2004). Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10:4325-4331.
38. Carino C, AB Olawaiye, S Cherfils, T Serikawa, MP Lynch, BR Rueda and RR Gonzalez. (2008). Leptin regulation of proangiogenic molecules in benign and cancerous endometrial cells. Int J Cancer 123:2782-2790.
39. Anagnostoulis S, AJ Karayiannakis, M Lambropoulou, A Efthimiadou, A Polychronidis and C Simopoulos. (2008). Human leptin induces angiogenesis in vivo. Cytokine 42: 353-357.
40. Bouloumie A, HC Drexler, M Lafontan and R Busse. (1998). Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059-1066.
41. Cao R, E Brakenhielm, C Wahlestedt, J Thyberg and Y Cao. (2001). Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 98:6390-6395.
42. Gimble JM, AJ Katz and BA Bunnell. (2007). Adiposederived stem cells for regenerative medicine. Circ Res 100: 1249-1260.
43. Zhang P, N Moudgill, E Hager, N Tarola, C Dimatteo, S McIlhenny, T Tulenko and PJ DiMuzio. (2001). Endothelial differentiation of adipose-derived stem cells from elderly patients with cardiovascular disease. Stem Cells Dev 20: 977-988.
44. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228.
45. Sauer H, F Sharifpanah, M Hatry, P Steffen, C Bartsch, R Heller, M Padmasekar, HP Howaldt, G Bein and M Wartenberg. (2011). NOS inhibition synchronizes calcium oscillations in human adipose tissue-derived mesenchymal stem cells by increasing gap-junctional coupling. J Cell Physiol 226:1642-1650.
46. Ucuzian AA and HP Greisler. (2007). In vitro models of angiogenesis. World J Surg 31:654-663.
47. Stone D, M Phaneuf, N Sivamurthy, FW LoGerfo and WC Quist. (2002). A biologically active VEGF construct in vitro: implications for bioengineering-improved prosthetic vascular grafts. J Biomed Mater Res A 59:160-165.
48. Brahimi-Horn MC and J Pouyssegur. (2007). Oxygen, a source of life and stress. FEBS Lett 581:3582-3591.
49. Khundmiri SJ, V Amin, J Henson, J Lewis, M Ameen, MJ Rane and NA Delamere. (2007). Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proxi- mal tubule cells through an ERK-dependent pathway. Am J Physiol Cell Physiol 293:C1171-C1180.
50. Bekhite MM, A Finkensieper, S Binas, J Muller, R Wetzker, HR Figulla, H Sauer and M Wartenberg. (2011). VEGFmediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells. J Cell Sci 124:1819-1830.
51. Calleja V, M Laguerre, PJ Parker and B Larijani (2009). Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol 7:e17.
52. Spiekermann K, F Faber, R Voswinckel andWHiddemann. (2002). The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Exp Hematol 30:767-773.
53. Ratajczak MZ, B Machalinski, W Wojakowski, J Ratajczak and M Kucia. (2007). A hypothesis for an embryonic origin of pluripotent Oct-4( + ) stem cells in adult bone marrow and other tissues. Leukemia 21:860-867.
54. Lakhani SA, A Masud, K Kuida, GA Porter, CJ Booth, WZ Mehal, I Inayat and RA Flavell. (2006). Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311:847-851.
55. Garnier P, A Prigent-Tessier, M Van Hoecke, N Bertrand, C Demougeot, O Sordet, RA Swanson, C Marie and A Beley. (2004). Hypoxia induces caspase-9 and caspase-3 activation without neuronal death in gerbil brains. Eur J Neurosci 20:937-946.
56. Suga H, T Shigeura, D Matsumoto, K Inoue, H Kato, N Aoi, S Murase, K Sato, K Gonda, I Koshima and K Yoshimura. (2007). Rapid expansion of human adiposederived stromal cells preserving multipotency. Cytotherapy 9:738-745.
57. Esser S, MG Lampugnani, M Corada, E Dejana and W Risau. (1998). Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111 (Pt 13):1853-1865.
58. Wary KK, GD Thakker, JO Humtsoe and J Yang. (2003). Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol Cancer 2:25.
59. Wen W, J Lu, K Zhang and S Chen. (2008). Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila) 1:554-561.
60. Carmeliet P. (2003). Angiogenesis in health and disease. Nat Med 9:653-660.
61. Planat-Benard V, JS Silvestre, B Cousin, M Andre, M Nibbelink, R Tamarat, M Clergue, C Manneville, C Saillan- Barreau and M Duriez. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109:656-663.
62. Nesselmann C, W Li, N Ma and G Steinhoff. (2010). Stem cell-mediated neovascularization in heart repair. Ther Adv Cardiovasc Dis 4:27-42.
63. Buerk DG, RD Shonat, CE Riva and SD Cranstoun. (1993). O2 gradients and countercurrent exchange in the cat vitreous humor near retinal arterioles and venules. Microvasc Res 45:134-148.
64. Matsumoto A, S Matsumoto, AL Sowers, JW Koscielniak, NJ Trigg, P Kuppusamy, JB Mitchell, S Subramanian, MC Krishna and K Matsumoto. (2005). Absolute oxygen tension (pO(2)) in murine fatty and muscle tissue as determined by EPR. Magn Reson Med 54:1530-1535.
65. Pasarica M, OR Sereda, LM Redman, DC Albarado, DT Hymel, LE Roan, JC Rood, DH Burk and SR Smith. (2009). Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58: 718-725.
66. Yin J, Z Gao, Q He, D Zhou, Z Guo and J Ye. (2009). Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296:E333-E342.
67. De Ugarte DA, K Morizono, A Elbarbary, Z Alfonso, PA Zuk, M Zhu, JL Dragoo, P Ashjian, B Thomas and P Benhaim. (2003). Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174:101-109.
68. Martin RJ, GJ Hausman and DB Hausman. (1998). Regulation of adipose cell development in utero. Proc Soc Exp Biol Med 219:200-210.
69. Nnodim JO. (1987). Development of adipose tissues. Anat Rec 219:331-337.
70. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
71. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
72. Ashjian PH, AS Elbarbary, B Edmonds, D DeUgarte, M Zhu, PA Zuk, HP Lorenz, P Benhaim and MH Hedrick. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111:1922-1931.
73. Brzoska M, H Geiger, S Gauer and P Baer. (2005). Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 330:142-150.
74. Cao Y, Z Sun, L Liao, Y Meng, Q Han and RC Zhao. (2005). Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun 332: 370-379.
75. Seo MJ, SY Suh, YC Bae and JS Jung. (2005). Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 328:258-264.
76. Timper K, D Seboek, M Eberhardt, P Linscheid, M Christ- Crain, U Keller, B Muller and H Zulewski. (2006). Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 341:1135-1140.
77. Parker AM and AJ Katz. (2006). Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 6:567-578.
78. Strem BM, KC Hicok, M Zhu, I Wulur, Z Alfonso, RE Schreiber, JK Fraser and MH Hedrick. (2005). Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54:132-141.
79. Harris LJ, P Zhang, H Abdollahi, NA Tarola, C DiMatteo, SE McIlhenny, TN Tulenko and PJ DiMuzio. (2010). Availability of adipose-derived stem cells in patients undergoing vascular surgical procedures. J Surg Res 163: e105-e112.
80. Spangrude GJ, S Heimfeld and IL Weissman. (1988). Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62.
81. Weissman IL. (2000). Stem cells: units of development, units of regeneration, and units in evolution. Cell 100:157-168.
82. Gronthos S, DM Franklin, HA Leddy, PG Robey, RW Storms and JM Gimble. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 189:54-63.
83. Li TS, H Ito, M Hayashi, A Furutani, M Matsuzaki and K Hamano. (2005). Cellular expression of integrin-beta 1 is of critical importance for inducing therapeutic angiogenesis by cell implantation. Cardiovasc Res 65:64-72.
84. Eliceiri BP. (2000). Integrin and growth factor receptor crosstalk. Circ Res 89:1104-1110.
85. Adams JC and FM Watt. (1993). Regulation of development and differentiation by the extracellular matrix. Development 117:1183-1198.
86. Koh KK, SM Park and MJ Quon. (2008). Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 117:3238-3249.
87. Ribatti D, AS Belloni, B Nico, M Di Comite, E Crivellato and A Vacca. (2008). Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides 29:1596-1602.
88. Cooke JP and RK Oka. (2002). Does leptin cause vascular disease? Circulation 106:1904-1905.
89. Fernandez-Sanchez A, E Madrigal-Santillan, M Bautista, J Esquivel-Soto, A Morales-Gonzalez, C Esquivel-Chirino, I Durante-Montiel, G Sanchez-Rivera, C Valadez-Vega and JA Morales-Gonzalez. (2011). Inflammation, oxidative stress, and obesity. Int J Mol Sci 12:3117-3132.
90. Verma S, CH Wang, SH Li, AS Dumont, PW Fedak, MV Badiwala, B Dhillon, RD Weisel, RK Li, DA Mickle and DJ Stewart. (2002). A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106:913-919.
91. Blake GJ and PM Ridker. (2001). Novel clinical markers of vascular wall inflammation. Circ Res 89:763-771.
92. Singhal A, IS Farooqi, TJ Cole, S ORahilly, M Fewtrell, M Kattenhorn, A Lucas and J Deanfield. (2002). Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 106:1919-1924.
93. Miranville A, C Heeschen, C Sengenes, CA Curat, R Busse and A Bouloumie. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110:349-355.
94. Fitzpatrick TE and CH Graham. (1998). Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res 245:155-162.
95. Scannell G, K Waxman, ND Vaziri, J Zhang, CJ Kaupke, M Jalali and CC Hecht. (1995). Hypoxia-induced alterations of neutrophil membrane receptors. J Surg Res 59:141-145.
96. Hosogai N, A Fukuhara, K Oshima, Y Miyata, S Tanaka, K Segawa, S Furukawa, Y Tochino, R Komuro, M Matsuda and I Shimomura. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911.
97. Trayhurn P, B Wang and IS Wood. (2008). Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100:227-235.
98. Semenza GL. (2011). Regulation of metabolism by hypoxiainducible factor 1. Cold Spring Harb Symp Quant Biol 76:347-353.
99. Appelhoff RJ, YM Tian, RR Raval, H Turley, AL Harris, CW Pugh, PJ Ratcliffe and JM Gleadle. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279:38458-38465.
100. Ginouves A, K Ilc, N Macias, J Pouyssegur and E Berra. (2008). PHDs overactivation during chronic hypoxia desensitizes HIFalpha and protects cells from necrosis. Proc Natl Acad Sci U S A 105:4745-4750.
101. Kietzmann T and K Jungermann. (1997). Modulation by oxygen of zonal gene expression in liver studied in primary rat hepatocyte cultures. Cell Biol Toxicol 13:243-255.
102. McKinley BA and BD Butler. (1999). Comparison of skeletal muscle PO2, PCO2, and pH with gastric tonometric P(CO2) and pH in hemorrhagic shock. Crit Care Med 27:1869-1877.
103. Saltzman DJ, A Toth, AG Tsai, M Intaglietta and PC Johnson. (2003). Oxygen tension distribution in postcapillary venules in resting skeletal muscle. Am J Physiol Heart Circ Physiol 285:H1980-H1985.
104. Wild JM, S Fichele, N Woodhouse, MN Paley, L Kasuboski and EJ van Beek. (2005). 3D volume-localized pO2 measurement in the human lung with 3He MRI. Magn Reson Med 53:1055-1064.
105. Tondevold E, J Eriksen and E Jansen. (1979). Observations on long bone medullary pressures in relation to arterial PO2, PCO2 and pH in the anaesthetized dog. Acta Orthop Scand 50:645-651.
106. Roemeling-van Rhijn M, FK Mensah, SS Korevaar, MJ Leijs, GJ van Osch, JN Ijzermans, MG Betjes, CC Baan, W Weimar and MJ Hoogduijn. (2013). Effects of hypoxia on the immunomodulatory properties of adipose tissue-derived mesenchymal stem cells. Front Immunol 4:203.
107. Efimenko A, E Starostina, N Kalinina and A Stolzing. (2011). Angiogenic properties of aged adipose derived mesenchymal stem cells after hypoxic conditioning. J Transl Med 9:10.
108. Hoeben A, B Landuyt, MS Highley, H Wildiers, AT Van Oosterom and EA De Bruijn. (2004). Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549-580.
109. Balligand JL, RA Kelly, PA Marsden, TW Smith and T Michel. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A 90:347-351.
110. Kelly RA, JL Balligand and TW Smith. (1996). Nitric oxide and cardiac function. Circ Res 79:363-380.
111. Palmer RM, AG Ferrige and S Moncada. (1987). Nitric oxide release accounts for the biological activity of endothelium- derived relaxing factor. Nature 327:524-526.
112. Ignarro LJ, GM Buga, KS Wood, RE Byrns and G Chaudhuri. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84:9265-9269.
113. Fischer LJ, S McIlhenny, T Tulenko, N Golesorkhi, P Zhang, R Larson, J Lombardi, I Shapiro and PJ DiMuzio. (2009). Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J Surg Res 152:157-166.
114. Shi CZ, XP Zhang, ZW Lv, HL Zhang, JZ Xu, ZF Yin, YQ Yan andCQ Wang. (2012). Adipose tissue-derived stem cells embedded with eNOS restore cardiac function in acute myocardial infarction model. Int J Cardiol 154:2-8.
115. Berardi GR, CK Rebelatto, HF Tavares, M Ingberman, P Shigunov, F Barchiki, AM Aguiar, NI Miyague, JC Francisco and A Correa. (2011). Transplantation of SNAPtreated adipose tissue-derived stem cells improves cardiac function and induces neovascularization after myocardium infarct in rats. Exp Mol Pathol 90:149-156.
116. McIlhenny S, P Zhang, T Tulenko, J Comeau, S Fernandez, A Policha, M Ferroni, E Faul, G Bagameri, I Shapiro and P Dimuzio. (2013). eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineering. J Tissue Eng Regen Med [Epub ahead of print]; DOI: 10.1002/term.1645.
117. Sweeney G. (2002). Leptin signalling. Cell Signal 14:655-663.
118. Tartaglia LA. (1997). The leptin receptor. J Biol Chem 272: 6093-6096.
119. Garonna E, KM Botham, GM Birdsey, AM Randi, RR Gonzalez-Perez and CP Wheeler-Jones. (2011). Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase- 2 with pro-angiogenic actions of leptin on human endothelial cells. PloS One 6:e18823.